Rapid molecular diagnostics to detect resistance to second-line anti-TB drugs
Int J Tuberc Lung Dis
.
2022 May 1;26(5):385-387.
doi: 10.5588/ijtld.22.0121.
Authors
A L Kritski
1
,
M Viveiros
2
,
A C C Carvalho
3
Affiliations
1
Academic Tuberculosis Program, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
2
Global Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Portugal.
3
Laboratory of Innovations in Therapies, Education and Bioproducts, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, RJ, Brazil.
PMID:
35505483
DOI:
10.5588/ijtld.22.0121
No abstract available
Publication types
Editorial
Comment
MeSH terms
Extensively Drug-Resistant Tuberculosis*
Humans
Pathology, Molecular
Tuberculosis, Multidrug-Resistant* / diagnosis
Tuberculosis, Multidrug-Resistant* / drug therapy